Archit Organosys has received approval to transfer 81,000 equity shares (i.e. stake of 81%) of Rs 10 each in its wholly owned subsidiary namely ‘Archit Life Science’. Upon completion of the aforesaid transfer, Archit Life Science will cease to be the wholly owned subsidiary of the Company. The Board of Directors of the Company at its meeting held on June 17, 2023 has approved the same.
Archit Organosys is on the forefront in the Indian Chemical Industry, producing a variety of Organic Chemicals, Pigments, Specialty Derivatives, Cosmetic Products, Adhesives & Sealants.
| Company Name | CMP |
|---|---|
| BASF India | 3653.10 |
| Tata Chemicals | 704.05 |
| SRF | 2464.40 |
| Pidilite Inds. | 1390.15 |
| Deepak Nitrite | 1537.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: